New diabetes clinical trial: A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

Published on: August 24, 2023 at 11:00AM
Condition:   Type 2 Diabetes
Intervention:   Drug: Orforglipron
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/efup1Mj